Current Cardiovascular Risk Reports最新文献

筛选
英文 中文
Atrial Fibrillation in Women: from Epidemiology to Treatment 女性房颤:从流行病学到治疗
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-10-06 DOI: 10.1007/s12170-022-00707-w
K. Tamirisa, C. Dye, I. Ekeruo, A. Volgman
{"title":"Atrial Fibrillation in Women: from Epidemiology to Treatment","authors":"K. Tamirisa, C. Dye, I. Ekeruo, A. Volgman","doi":"10.1007/s12170-022-00707-w","DOIUrl":"https://doi.org/10.1007/s12170-022-00707-w","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"1 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2022-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41801256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
New Strategies for Lowering Low Density Lipoprotein Cholesterol for Cardiovascular Disease Prevention. 降低低密度脂蛋白胆固醇预防心血管疾病的新策略。
IF 2
Current Cardiovascular Risk Reports Pub Date : 2022-09-01 Epub Date: 2022-06-25 DOI: 10.1007/s12170-022-00694-y
Sean Paul Gaine, Renato Quispe, Jaideep Patel, Erin D Michos
{"title":"New Strategies for Lowering Low Density Lipoprotein Cholesterol for Cardiovascular Disease Prevention.","authors":"Sean Paul Gaine, Renato Quispe, Jaideep Patel, Erin D Michos","doi":"10.1007/s12170-022-00694-y","DOIUrl":"10.1007/s12170-022-00694-y","url":null,"abstract":"<p><strong>Purpose of review: </strong>The primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) relies on optimizing cardiovascular health and appropriate pharmacotherapy, a mainstay of which is low-density lipoprotein-cholesterol (LDL-C) lowering. Typically, statin therapy remains the first line approach. Advances in technology and understanding of lipid metabolism have facilitated the development of several novel therapeutic targets and medications within the last decade. This review focuses on medications recently approved by the U.S. Food and Drug Administration (FDA) for the reduction of LDL-C and ASCVD risk, as well as new therapies in the pipeline.</p><p><strong>Recent findings: </strong>Novel lipid therapies aim to lower risk of ASCVD by targeting reduction of atherogenic compounds, such as LDL, lipoprotein(a) (Lp(a)), and triglyceride-rich lipoproteins. Evolocumab and alirocumab, monoclonal antibody proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors which lower LDL-C by approximately 60%, have emerged as important therapies for use in patients with ASCVD as well as familial hypercholesterolemia (FH). Bempedoic acid, an ATP citrate lyase inhibitor, is an oral medication recently approved that can lower LDL-C by approximately 18% alone and 38% when combined with ezetimibe. Inclisiran, a small-interfering RNA (siRNA) molecule which inhibits the translation of PCSK9, is the most recently FDA-approved LDL-C lowering medication, and can reduce LDL-C by approximately 50% with twice yearly subcutaneous dosing. The cardiovascular outcome trials for bempedoic acid and inclisiran are still on-going. Evinacumab, a monoclonal antibody which targets angiopoietin-like protein 3 (ANGPTL3), has been approved for use in patients with homozygous FH. SiRNAs and anti-sense oligonucleotides (ASO) facilitating selective inhibition of the production of targeted proteins including Lp(a) and ANGLPTL3 are active areas of clinical investigation.</p><p><strong>Summary: </strong>Recently several novel LDL-C lowering medications have been approved. New therapeutic targets have been identified and present additional means of lowering LDL-C and other atherogenic compounds for patients who remain at high ASCVD risk.</p>","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 9","pages":"69-78"},"PeriodicalIF":2.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543364/pdf/nihms-1819176.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10133436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary Artery Calcium-Based Approach to Lipid Management 基于钙的冠状动脉脂质管理方法
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-08-19 DOI: 10.1007/s12170-022-00704-z
Ayeeshik Kole, P. Joshi
{"title":"Coronary Artery Calcium-Based Approach to Lipid Management","authors":"Ayeeshik Kole, P. Joshi","doi":"10.1007/s12170-022-00704-z","DOIUrl":"https://doi.org/10.1007/s12170-022-00704-z","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"1 1","pages":"1 - 14"},"PeriodicalIF":1.9,"publicationDate":"2022-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47924432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Triglyceride-Rich Lipoproteins, Remnants, and Atherosclerotic Cardiovascular Disease Risk 富含甘油三酯的脂蛋白、残留物与动脉粥样硬化性心血管疾病风险
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-07-23 DOI: 10.1007/s12170-022-00702-1
V. Bharadiya, Swasti Rawal, V. Jain, P. Chevli, Anurag Mehta
{"title":"Triglyceride-Rich Lipoproteins, Remnants, and Atherosclerotic Cardiovascular Disease Risk","authors":"V. Bharadiya, Swasti Rawal, V. Jain, P. Chevli, Anurag Mehta","doi":"10.1007/s12170-022-00702-1","DOIUrl":"https://doi.org/10.1007/s12170-022-00702-1","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 1","pages":"131 - 144"},"PeriodicalIF":1.9,"publicationDate":"2022-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45421694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular Health of Black Women Before, During, and After Pregnancy: A Call to Action and Implications for Prevention 黑人妇女怀孕前、怀孕期间和怀孕后的心血管健康:对行动的呼吁和预防的影响
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-07-23 DOI: 10.1007/s12170-022-00703-0
R. Bond, Kameelah Phillips, Kendra N. Ivy, Vanessa Ogueri, B. Parapid, S. C. Miller, Annette K. Ansong
{"title":"Cardiovascular Health of Black Women Before, During, and After Pregnancy: A Call to Action and Implications for Prevention","authors":"R. Bond, Kameelah Phillips, Kendra N. Ivy, Vanessa Ogueri, B. Parapid, S. C. Miller, Annette K. Ansong","doi":"10.1007/s12170-022-00703-0","DOIUrl":"https://doi.org/10.1007/s12170-022-00703-0","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 1","pages":"171-180"},"PeriodicalIF":1.9,"publicationDate":"2022-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43019176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Racial and Ethnic Disparities in Cardiovascular Disease Risk Among Patients with Chronic Kidney Disease 慢性肾脏病患者心血管疾病风险的种族和民族差异
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-07-23 DOI: 10.1007/s12170-022-00701-2
D. Adedinsewo, Ivan E. Porter, R. White, L. Hickson
{"title":"Racial and Ethnic Disparities in Cardiovascular Disease Risk Among Patients with Chronic Kidney Disease","authors":"D. Adedinsewo, Ivan E. Porter, R. White, L. Hickson","doi":"10.1007/s12170-022-00701-2","DOIUrl":"https://doi.org/10.1007/s12170-022-00701-2","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 1","pages":"145 - 157"},"PeriodicalIF":1.9,"publicationDate":"2022-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44491779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Sex Differences in Cardiomyopathy 心肌病的性别差异
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-07-22 DOI: 10.1007/s12170-022-00700-3
Chris Taylor, Emily S. Lau
{"title":"Sex Differences in Cardiomyopathy","authors":"Chris Taylor, Emily S. Lau","doi":"10.1007/s12170-022-00700-3","DOIUrl":"https://doi.org/10.1007/s12170-022-00700-3","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 1","pages":"159 - 170"},"PeriodicalIF":1.9,"publicationDate":"2022-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45314500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using Atrial Fibrillation Symptoms to Guide Treatment: Becoming PROs at Improving Quality of Life 利用房颤症状指导治疗:成为提高生活质量的专家
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-07-22 DOI: 10.1007/s12170-022-00695-x
B. Zenger, B. Steinberg
{"title":"Using Atrial Fibrillation Symptoms to Guide Treatment: Becoming PROs at Improving Quality of Life","authors":"B. Zenger, B. Steinberg","doi":"10.1007/s12170-022-00695-x","DOIUrl":"https://doi.org/10.1007/s12170-022-00695-x","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 1","pages":"79 - 86"},"PeriodicalIF":1.9,"publicationDate":"2022-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45274981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Arrhythmia-Induced Cardiomyopathy: Mechanisms and Risk Assessment to Guide Management and Follow-Up 心律失常引起的心肌病:机制和风险评估指导管理和随访
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-07-18 DOI: 10.1007/s12170-022-00699-7
Luke Chong, R. Gopinathannair, Ali Ahmad, Philip L. Mar, B. Olshansky
{"title":"Arrhythmia-Induced Cardiomyopathy: Mechanisms and Risk Assessment to Guide Management and Follow-Up","authors":"Luke Chong, R. Gopinathannair, Ali Ahmad, Philip L. Mar, B. Olshansky","doi":"10.1007/s12170-022-00699-7","DOIUrl":"https://doi.org/10.1007/s12170-022-00699-7","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 1","pages":"121 - 129"},"PeriodicalIF":1.9,"publicationDate":"2022-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43446601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipoprotein(a)—When to Screen and How to Treat 脂蛋白(a) -何时筛查及如何治疗
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-07-11 DOI: 10.1007/s12170-022-00698-8
N. Patel, N. Mittal, P. Choubdar, P. Taub
{"title":"Lipoprotein(a)—When to Screen and How to Treat","authors":"N. Patel, N. Mittal, P. Choubdar, P. Taub","doi":"10.1007/s12170-022-00698-8","DOIUrl":"https://doi.org/10.1007/s12170-022-00698-8","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 1","pages":"111-120"},"PeriodicalIF":1.9,"publicationDate":"2022-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44537346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信